Anxiety and depression in postmenopausal women.. Anxiety disorder due to known physiological condition
Conditions
Interventions
Intervention 1: Intervention group: For this patient if they had the inclusion criteria, after submitting a description and obtaining informed consent, The DAAS-21 questionnaire and the demographic in
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: Interested in participating in the study. Having at least elementary education. 45-60 years old. Amenorrhea for 1 year. Mild to moderate anxiety and depression symptoms (according DASS scale).
Exclusion criteria
Exclusion criteria: Having allergy to chamomile. Major depression that need to special treatment. Person who have suicidal thoughts and self-harm. Having renal, liver, cardiac and thyroid disease, Bleeding disorder and malignancies, degenerative, auto immune and psychological disorder. Using of anti-depression and sedative drugs in 3 months ago. Having a history of stressful events or tragic events in recent months such as the death of a spouse or close persons. Having a history of drug abuser or alcohol abuse.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety and depression in postmenopausal women. Timepoint: Pre-intervention, 4 weeks after the start of the intervention, 8 weeks after the start of the intervention. Method of measurement: Variables are measured by demographic questionnaire and DAAS-21 scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Anxiety and depression in postmenopausal women. Timepoint: Pre-intervention, 4 weeks after the start of the intervention, 8 weeks after the start of the intervention. Method of measurement: Variables are measured by demographic questionnaire and DAAS-21 scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZohreh Zamanpour
Ahvaz University of Medical Sciences
Outcome results
None listed